サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678546

避妊薬・避妊器具の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2025年～2030年

Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
避妊薬・避妊器具の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2025年～2030年
出版日: 2025年02月05日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場規模と動向

世界の避妊薬・避妊器具市場規模は2024年に311億8,000万米ドルと推定され、2025～2030年にかけてCAGR 6.0%で成長すると予測されています。

避妊薬市場の成長にはいくつかの要因が寄与しています。リプロダクティブヘルス（性とリプロダクティブヘルス）に対する認識と教育の高まり、家族計画法に対する需要の高まり、医療インフラとアクセスの改善、より効果的で利便性の高い避妊オプションへの消費者の嗜好の変化などが主要促進要因です。これらの要因により、経口避妊薬や、子宮内避妊器具（IUD）やインプラントなどの長時間作用型可逆的避妊薬（LARC）など、幅広い避妊法の選択肢が世界的に求められています。

さらに、10代の妊娠に関する健康上の懸念、最新の避妊法に対する意識の高まり、計画外の妊娠を防ぐ主要手段としての経口避妊薬への嗜好の高まりが、予測期間中の市場成長を促進すると予想されます。加えて、製品イノベーションの進展、政府のイニシアティブ、女性のエンパワーメントと権利の重視がこの市場成長に寄与しています。例えば、2023年7月には、プロゲスチンのみの経口避妊薬であるオピルがFDAから非配合用として承認を取得しました。

望まない妊娠とそれに関連する医療コストの削減を目的としたプログラムの実施と、ユーザー間の意識の向上が、予測期間中の産業の成長を促進すると予想されます。国連人口基金（UNFPA）の「2022年世界人口の現状報告書」によると、世界では毎年約1億2,100万人が妊娠しており、その半数近くが望まない妊娠です。

さらに、発展途上国の政府は、避妊に対する認識とアクセスを高めるための措置を講じています。例えば、2023年10月、インドのカルナータカ保健省は、国家家族計画プログラムのもと、女性向けに2つの新しい避妊法を開始しました。皮下インプラントと皮下注射は、政府が運営する保健センターで利用できるようになり、2回の出産間隔を延ばすことで生殖と性の健康を促進します。こうした避妊法は新興国市場での避妊を促進し、市場開拓に貢献すると期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 避妊薬・避妊器具市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場の動向
    • 市場促進要因分析
    • 市場抑制要因分析
    • 産業の課題
    • 市場機会分析
  • 避妊薬・避妊器具市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 避妊薬・避妊器具市場： 製品別、推定・動向分析

  • 定義と範囲
  • 製品市場シェア分析、2024年と2030年
  • セグメントダッシュボード
  • 避妊薬・避妊器具市場：製品別、2018～2030年
    • 避妊薬
    • 避妊器具

第5章 避妊薬・避妊器具市場：地域別、推定・動向分析

  • 定義と範囲
  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 避妊薬・避妊器具の市場シェア、地域別、2024年と2030年、
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 最近の動向/主要市場参入企業による戦略的取り組みと影響分析
  • 企業分類
  • 企業の市況分析
  • 戦略マッピング
  • 企業プロファイル
    • AbbVie Inc.
    • Afaxys, Inc.
    • Agile Therapeutics
    • Bayer AG
    • China Resources（Holdings）Co., Ltd.
    • Church & Dwight Co., Inc.
    • Cupid Limited
    • Helm AG
    • Johnson & Johnson Services, Inc.
    • Organon Group
    • Pfizer Inc.
    • Veru, Inc.
    • Viatris Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 4 U.S. contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 5 Canada contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 6 Mexico contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 7 Europe contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 8 UK contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 9 Germany contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 10 France contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 11 Italy contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 12 Spain contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 13 Denmark contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 14 Sweden contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 15 Norway contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 17 Japan contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 18 China contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 19 India contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 20 Australia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 21 South Korea contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 22 Thailand contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 23 Latin America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 24 Brazil contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 25 Argentina contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 26 MEA contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 27 South Africa contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 28 Saudi Arabia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 29 UAE contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
  • Table 30 Kuwait contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Contraceptive Drugs and Devices Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 Contraceptive Drugs and Devices- Market Size and Growth Prospects (USD Billion)
  • Fig. 11 Contraceptive Drugs and Devices Market: Market Dynamics
  • Fig. 12 Contraceptive Drugs and Devices Market: PORTER's Analysis
  • Fig. 13 Contraceptive Drugs and Devices Market: PESTEL Analysis
  • Fig. 14 Contraceptive Drugs and Devices Market Share by Product 2024 & 2030 (USD Billion)
  • Fig. 15 Contraceptive Drugs and Devices Market, by Product: Key Takeaways
  • Fig. 16 Contraceptive Drugs and Devices Market, by Product: Market Share, 2024 & 2030
  • Fig. 17 Contraceptive Drugs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 18 Contraceptive Pills Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 19 Patch Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 20 Injectable Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 21 Contraceptive Devices Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 22 Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 23 Male Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 24 Female Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 25 Subdermal Implants Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 26 Intrauterine Devices (IUDs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 27 Copper IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 28 Hormonal IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 29 Vaginal Ring Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 30 Diaphragm Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 31 Contraceptive Drugs and Devices Market Revenue, by Region, 2024 & 2030 (USD Billion)
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030) (USD Billion)
  • Fig. 40 Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 MEA Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Key Company Categorization
  • Fig. 63 Company Market Positioning
  • Fig. 64 Key Company Market Share Analysis, 2024
  • Fig. 65 Strategic Framework
目次
Product Code: 978-1-68038-032-3

Market Size & Trends:

The global contraceptive drugs and devices market size was estimated at USD 31.18 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. Several factors are contributing to the growth of the contraceptive market. Increasing awareness and education about reproductive health, a rising demand for family planning methods, improved healthcare infrastructure and access, and a shift in consumer preferences toward more effective and convenient contraceptive options are all key drivers. These factors have led to a global demand for a wide range of contraceptive choices, including oral contraceptives and long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants.

Furthermore, health concerns related to teenage pregnancies, increased awareness of modern contraception methods, and a growing preference for oral contraceptives as the primary means of preventing unplanned pregnancies are anticipated to drive market growth during the forecast period. In addition, advancements in product innovation, government initiatives, and a focus on women's empowerment and rights have contributed to this market growth. For instance, in July 2023, Opill, a progestin-only oral contraceptive pill, got approval by the FDA for nonprescription use.

Implementing programs aimed at reducing unwanted pregnancies and related healthcare costs, along with increasing awareness among users, is expected to drive growth in the industry during the forecast period. According to the 2022 State of World Population Report by the United Nations Population Fund (UNFPA), approximately 121 million pregnancies occur worldwide each year, with nearly half of them being unintended.

Moreover, governments in developing countries are undertaking steps to increase awareness and access to contraceptives. For instance, in October 2023, the Karnataka Health Department in India launched two new contraceptive methods for women under the National Family Planning Programme. The sub-dermal implant and subcutaneous injection were made available at government-run health centers to promote reproductive and sexual health by extending the interval between two births. Such methods are expected to promote the use of contraception in developing countries and contribute to the market's growth.

Global Contraceptive Drugs And Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global contraceptive drugs and devices market report based on product, and region.

  • Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Contraceptive Drugs
    • Contraceptive Pills
    • Patch
    • Injectable
  • Contraceptive Devices
    • Condoms
    • Male Condoms
    • Female Condoms
    • Subdermal Implants
    • Intrauterine Devices (IUDs)
    • Copper IUDs
    • Hormonal IUDs
    • Vaginal Ring
    • Diaphragm
  • Regional Outlook (Revenue, USD Billion, 2018-2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Secondary Sources
    • 1.4.2. List of Primary Sources
    • 1.4.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamic
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing awareness and education on reproductive health
      • 3.2.1.2. Rising demand for family planning methods
      • 3.2.1.3. Growing healthcare infrastructure and access
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects and health concerns
    • 3.2.3. Industry Challenges
    • 3.2.4. Market Opportunity Analysis
  • 3.3. Contraceptive Drugs and Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Contraceptive Drugs and Devices Market: By Product, 2018 to 2030
    • 4.4.1. Contraceptive Drugs
      • 4.4.1.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.2. Contraceptive Pills
        • 4.4.1.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.3. Patch
        • 4.4.1.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.1.4. Injectable
        • 4.4.1.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. Contraceptive Devices
      • 4.4.2.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.2. Condoms
        • 4.4.2.2.1. Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.2.2. Male Condoms
          • 4.4.2.2.2.1. Male Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.2.3. Female Condoms
          • 4.4.2.2.3.1. Female Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.3. Subdermal Implants
        • 4.4.2.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.4. Intrauterine Devices (IUDs)
        • 4.4.2.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.4.2. Copper IUDs
          • 4.4.2.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
        • 4.4.2.4.3. Hormonal IUDs
          • 4.4.2.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.5. Vaginal Ring
        • 4.4.2.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.4.2.6. Diaphragm
        • 4.4.2.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis by Region, Product

  • 5.1. Definition and Scope
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Regional Market Dashboard
  • 5.4. Contraceptive Drugs and Devices Market Share, By Region, 2024 & 2030, (USD Billion)
  • 5.5. North America
    • 5.5.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.2. U.S.
      • 5.5.2.1. U.S. Key Country Dynamics
      • 5.5.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3. Canada
      • 5.5.3.1. Canada Key Country Dynamics
      • 5.5.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.4. Mexico
      • 5.5.4.1. Mexico Key Country Dynamics
      • 5.5.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Europe
    • 5.6.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. UK
      • 5.6.2.1. UK Key Country Dynamics
      • 5.6.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. U.K. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. Germany
      • 5.6.3.1. Germany Key Country Dynamics
      • 5.6.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.4. France
      • 5.6.4.1. France Key Country Dynamics
      • 5.6.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.5. Italy
      • 5.6.5.1. Italy Key Country Dynamics
      • 5.6.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.6. Spain
      • 5.6.6.1. Spain Key Country Dynamics
      • 5.6.6.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.7. Denmark
      • 5.6.7.1. Denmark Spain Key Country Dynamics
      • 5.6.7.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.8. Sweden
      • 5.6.8.1. Sweden Key Country Dynamics
      • 5.6.8.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.8.3. Competitive Insights
      • 5.6.8.4. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.9. Norway
      • 5.6.9.1. Norway Key Country Dynamics
      • 5.6.9.2. Regulatory Landscape and Reimbursement Scenario
      • 5.6.9.3. Competitive Insights
      • 5.6.9.4. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.2. China
      • 5.7.2.1. China Key Country Dynamics
      • 5.7.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.3. Japan
      • 5.7.3.1. Japan Key Country Dynamics
      • 5.7.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.4. India
      • 5.7.4.1. India Key Country Dynamics
      • 5.7.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.4.3. Competitive Insights
      • 5.7.4.4. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.5. South Korea
      • 5.7.5.1. South Korea Key Country Dynamics
      • 5.7.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.5.3. Competitive Insights
      • 5.7.5.4. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.6. Australia
      • 5.7.6.1. Australia Key Country Dynamics
      • 5.7.6.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.6.3. Competitive Insights
      • 5.7.6.4. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.7. Thailand
      • 5.7.7.1. Thailand Key Country Dynamics
      • 5.7.7.2. Regulatory Landscape and Reimbursement Scenario
      • 5.7.7.3. Competitive Insights
      • 5.7.7.4. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Latin America
    • 5.8.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.2. Brazil
      • 5.8.2.1. Brazil Key Country Dynamics
      • 5.8.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.3. Argentina
      • 5.8.3.1. Argentina Key Country Dynamics
      • 5.8.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Middle East and Africa (MEA)
    • 5.9.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.2. South Africa
      • 5.9.2.1. South Africa Key Country Dynamics
      • 5.9.2.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.2.3. Competitive Insights
      • 5.9.2.4. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Saudi Arabia Key Country Dynamics
      • 5.9.3.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.3.3. Competitive Insights
      • 5.9.3.4. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.4. UAE
      • 5.9.4.1. UAE Key Country Dynamics
      • 5.9.4.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.4.3. Competitive Insights
      • 5.9.4.4. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.9.5. Kuwait
      • 5.9.5.1. Kuwait Key Country Dynamics
      • 5.9.5.2. Regulatory Landscape and Reimbursement Scenario
      • 5.9.5.3. Competitive Insights
      • 5.9.5.4. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments/ Strategic Initiatives & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Position Analysis
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles
    • 6.5.1. AbbVie Inc.
      • 6.5.1.1. Participant's Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Recent Developments/ Strategic Initiatives
    • 6.5.2. Afaxys, Inc.
      • 6.5.2.1. Participant's Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Recent Developments/ Strategic Initiatives
    • 6.5.3. Agile Therapeutics
      • 6.5.3.1. Participant's Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Recent Developments/ Strategic Initiatives
    • 6.5.4. Bayer AG
      • 6.5.4.1. Participant's Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Recent Developments/ Strategic Initiatives
    • 6.5.5. China Resources (Holdings) Co., Ltd.
      • 6.5.5.1. Participant's Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Recent Developments/ Strategic Initiatives
    • 6.5.6. Church & Dwight Co., Inc.
      • 6.5.6.1. Participant's Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Recent Developments/ Strategic Initiatives
    • 6.5.7. Cupid Limited
      • 6.5.7.1. Participant's Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Recent Developments/ Strategic Initiatives
    • 6.5.8. Helm AG
      • 6.5.8.1. Participant's Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Recent Developments/ Strategic Initiatives
    • 6.5.9. Johnson & Johnson Services, Inc.
      • 6.5.9.1. Participant's Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Recent Developments/ Strategic Initiatives
    • 6.5.10. Organon Group
      • 6.5.10.1. Participant's Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Recent Developments/ Strategic Initiatives
    • 6.5.11. Pfizer Inc.
      • 6.5.11.1. Participant's Overview
      • 6.5.11.2. Financial Performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Recent Developments/ Strategic Initiatives
    • 6.5.12. Veru, Inc.
      • 6.5.12.1. Participant's Overview
      • 6.5.12.2. Financial Performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Recent Developments/ Strategic Initiatives
    • 6.5.13. Viatris Inc.
      • 6.5.13.1. Participant's Overview
      • 6.5.13.2. Financial Performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Recent Developments/ Strategic Initiatives